The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predicting sensitivity to palbociclib with early circulating tumor DNA dynamics in the PALOMA-3 trial.
 
Ben O'Leary
Research Funding - Pfizer (Inst)
 
Sarah Hrebien
No Relationships to Disclose
 
James P Morden
No Relationships to Disclose
 
Matthew Beaney
Employment - Randox
Stock and Other Ownership Interests - Randox (I)
 
Yuan Liu
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Cynthia Huang Bartlett
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Maria Koehler
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Massimo Cristofanilli
Honoraria - Agendia; Celgene; Dompé Farmaceutici; Pfizer
Consulting or Advisory Role - Cynvenio Biosystems; Dompé Farmaceutici; Newomics; Vortex Biosciences
 
Isaac Garcia-Murillas
No Relationships to Disclose
 
Judith Bliss
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Janssen (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Nicholas C. Turner
Consulting or Advisory Role - ADC Therapeutics; AstraZeneca; Novartis; Pfizer; Puma Biotechnology; Roche; SERVIER; Synthon
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Inivata (Inst); Pfizer (Inst); Roche (Inst)